MIRA INFORM REPORT

 

 

Report Date :           

06.09.2011

 

IDENTIFICATION DETAILS

 

Name :

AGITO MEDICAL APS

 

 

Registered Office :

Virkelyst 10, Norresundby, 9400

 

 

Country :

Denmark

 

 

Financials (as on) :

31.12.2009

 

 

Year of Establishment :

2004

 

 

Com. Reg. No.:

27770851

 

 

Legal Form :

Private Independent Company

 

 

Line of Business :

Merchant Wholesale Distribution of biological and medical products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Moderate

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

----

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

Denmark

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name & address   Bottom of Form

 

 

Agito Medical ApS

Virkelyst 10

Norresundby, 9400

Denmark

Tel:       +45 96 35 01 70

Fax:      +45 96 35 01 30

Web:    www.agitomedical.com

 

 

SYNTHESIS  

 

Employees:                   5

Company Type:            Private Independent

Incorporation Date:         2004   

Financials in:                 USD (Millions)

Fiscal Year End:            31-Dec-2010

Reporting Currency:       Danish Krone

Annual Sales:               0.0

Net Income:                   0.8

Total Assets:                 6.7

 

 

Business Description     

 

Agito Medical ApS is primarily engaged in the merchant wholesale distribution of biological and medical products; botanical drugs and herbs; and pharmaceutical products intended for internal and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

 

Industry 

Industry            Personal and Household Products

ANZSIC 2006:    3720 - Pharmaceutical and Toiletry Goods Wholesaling

NACE 2002:      5146 - Wholesale of pharmaceutical goods

NAICS 2002:     424210 - Drugs and Druggists' Sundries Merchant Wholesalers

UK SIC 2003:    5146 - Wholesale of pharmaceutical goods

US SIC 1987:    5122 - Drugs, Drug Proprietaries, and Druggists' Sundries

 

           


Key Executives   

 

Name

Title

Steen Lindequist

Managing Director / Director, Board Member

Solveig Blomvik

Board Member

Anders Fage Jensen

Board Member

Jonathan Tjoa Algreen

Bestyrelsesformand

 

Registered No.(DNK): 27770851

 

1 - Profit & Loss Item Exchange Rate: USD 1 = DKK 5.623146

2 - Balance Sheet Item Exchange Rate: USD 1 = DKK 5.55485

 

 

Corporate Overview

 

Location

Virkelyst 10

Nørresundby, 9400

Denmark

Tel:       +45 96 35 01 70

Fax:      +45 96 35 01 30

Web:    www.agitomedical.com

           

Sales DKK(mil):             0.0

Assets DKK(mil):           37.1

Employees:                   5

Fiscal Year End:            31-Dec-2010

Industry:                        Personal and Household Products

Incorporation Date:         2004

Company Type:             Private Independent

Quoted Status:              Not Quoted

Registered No.(DNK):     27770851

Managing Director /

Director, Board Member:  Steen Lindequist

 

Contents

·         Industry Codes

·         Business Description

·         Financial Data

 

Industry Codes

 

ANZSIC 2006 Codes:

3720     -          Pharmaceutical and Toiletry Goods Wholesaling

NACE 2002 Codes:

5146     -          Wholesale of pharmaceutical goods

 

NAICS 2002 Codes:

4242     -          Drugs and Druggists' Sundries Merchant Wholesalers

424210  -          Drugs and Druggists' Sundries Merchant Wholesalers

42421   -          Drugs and Druggists' Sundries Merchant Wholesalers

 

US SIC 1987:

5122     -          Drugs, Drug Proprietaries, and Druggists' Sundries

 

UK SIC 2003:

5146     -          Wholesale of pharmaceutical goods

 

Business Description

Agito Medical ApS is primarily engaged in the merchant wholesale distribution of biological and medical products; botanical drugs and herbs; and pharmaceutical products intended for internal and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

 

Financial Data

Financials in:

DKK(mil)

 

Revenue:

0.0

Net Income:

4.3

Assets:

37.1

Total Liabilities:

0.0

 

 

 

Date of Financial Data:

31-Dec-2010

 

1 Year Growth

NA

NA

NA

 

 

 

 

 

Executive report

 

Board of Directors

 

Name

Title

Function

 

Solveig Blomvik

 

Board Member

Director/Board Member

 

Anders Fage Jensen

 

Board Member

Director/Board Member

 

Steen Lindequist

 

Managing Director / Director, Board Member

Director/Board Member

 

Jonathan Tjoa Algreen

 

Bestyrelsesformand

Director/Board Member

 

 

Executives

 

Name

Title

Function

 

Steen Lindequist

 

Managing Director / Director, Board Member

Managing Director

 


 

 

Annual Profit & Loss

 

 

 

31-Dec-2009

31-Dec-2008

31-Dec-2007

Period Length

12 Months

12 Months

12 Months

Filed Currency

DKK

DKK

DKK

Exchange Rate (Period Average)

5.354263

5.097335

5.44373

Consolidated

No

No

No

 

 

 

 

Gross Profit

1.9

1.1

0.5

Operating Income

1.0

0.3

0.1

Net Income

0.7

0.2

0.1

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Dec-2009

31-Dec-2008

31-Dec-2007

Filed Currency

DKK

DKK

DKK

Exchange Rate

5.18625

5.35465

5.10005

Consolidated

No

No

No

 

 

 

 

Total Assets

3.7

1.7

0.9

Provisions

0.0

-

-

Total Liabilities

2.7

1.4

0.8

Total Equity

1.0

0.3

0.1

 

 

Annual Ratios

 

 

 

 

31-Dec-2009

31-Dec-2008

31-Dec-2007

Period Length

12 Months

12 Months

12 Months

Filed Currency

-

-

-

Exchange Rate

-

-

-

Consolidated

No

No

No

 

 

 

 

Current Ratio

137.04

126.75

129.33

Total debt/total equity

27.87

18.28

14.54

Return on average equity

68.59

59.93

59.24

 

Annual Growth Rates

 

 

 

 

31-Dec-2008

31-Dec-2007

Period Length

12 Months

12 Months

Filed Currency

-

-

Exchange Rate

-

-

Consolidated

No

No

 

 

 

Marginal Contribution Percent Change

76.32%

99.40%

Operating Results Percent Change

219.81%

162.44%

Profit/Loss for the Year Percent Change

264.31%

152.48%

Assets Percent Change

108.73%

98.47%

Debts Percent Change

84.18%

89.75%

Equity Capital Percent Change

218.33%

149.56%

Current Ratio Percent Change

8.12%

-1.99%

Debt/Equity Ratio Percent Change

52.46%

25.72%

Retun On Equity Percent Change

14.45%

1.16%

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.45.94

UK Pound

1

Rs.74.28

Euro

1

Rs.64.97

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.